Evaluation of relapse and defaulter pulmonary tuberculosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005
The evaluation of the relapse or treatment interrupted pulmonary tuberculosis cases Source: Eur Respir J 2006; 28: Suppl. 50, 21s Year: 2006
Relapse and failure pulmonary tuberculosis patients have the chance of cure with major antituberculosis drugs Source: Eur Respir J 2007; 30: Suppl. 51, 657s Year: 2007
Treatment outcomes of pulmonary tuberculosis cases in Izmit/Turkey Source: Eur Respir J 2004; 24: Suppl. 48, 651s Year: 2004
The characteristics of previous tuberculosis treatment programmes in patients with tuberculosis relapses Source: Eur Respir J 2001; 18: Suppl. 33, 473s Year: 2001
Delays in diagnosis and treatment of patients with smear-positive pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 689s Year: 2005
The assessment of risk factors and treatment of pulmonary TB relapses Source: Eur Respir J 2006; 28: Suppl. 50, 129s Year: 2006
Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001
Study of risk factors in relapses at patients with pulmonary tuberculosis. Their retreatment results Source: Eur Respir J 2001; 18: Suppl. 33, 467s Year: 2001
Survival and risk factors of mortality among defaulters from treatment of pulmonary tuberculosis Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012
Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019
Cause and outcome of relapse of tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 201s Year: 2004
Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis with delayed conversion over 4 months Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes Year: 2015
Diagnosis and treatment delay in patients with pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 520s Year: 2003
Recurrence after successful treatment among patients with multidrug-resistant tuberculosis Source: Annual Congress 2011 - Risk factors and treatment outcomes in multidrug- and extensively drug-resistant tuberculosis Year: 2011
Efficacy of a standard chemotherapy regimen in the management of sputum-positive pulmonary TB relapses Source: Eur Respir J 2003; 22: Suppl. 45, 41s Year: 2003
The reasons of unfavorable outcomes of treatment in pulmonary tuberculosis patients in Kyrgyzstan Source: Eur Respir J 2004; 24: Suppl. 48, 648s Year: 2004
Aspects of diagnosis and treatment in pulmonary tuberculosis in children Source: Eur Respir J 2002; 20: Suppl. 38, 168s Year: 2002
Retreatment of tuberculosis patients after the treatment interruption Source: Eur Respir J 2006; 28: Suppl. 50, 506s Year: 2006
Characteristics of smear-positive pulmonary tuberculosis patients with delayed diagnosis Source: Virtual Congress 2020 – Non-tuberculous mycobacteria and latent tuberculosis infection Year: 2020